Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients

European Heart Journal

Volumn 29, Issue 13, 2008, Pages 1681-1687

  Giardini, Alessandro ^a   Balducci, Anna ^a   Specchia, Salvatore ^a   Gargiulo, Gaetano ^a   Bonvicini, Marco ^a   Picchio, Fernando Maria ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cardiac output; Exercise; Fontan; Oxygen uptake

Indexed keywords

SILDENAFIL;

ABSENCE OF SIDE EFFECTS; ADULT; ARTERIAL OXYGEN SATURATION; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFICACY; EXERCISE TEST; FEMALE; FONTAN PROCEDURE; HEART INDEX; HEMODYNAMICS; HUMAN; LUNG BLOOD FLOW; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; REST; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; EXERCISE; EXERCISE TEST; FEMALE; FONTAN PROCEDURE; HEMODYNAMICS; HUMANS; MALE; OBSERVER VARIATION; OXYGEN CONSUMPTION; PIPERAZINES; PROSPECTIVE STUDIES; PURINES; SULFONES; VASODILATOR AGENTS;

EID: 46849112004     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn215     Document Type: Article

References (29)

1. Gentles TL, Mayer JE Jr, Gauvreau K, Newburger JW, Lock JE, Kupferschmid JP, Burnett J, Jonas RA, Castaneda AR, Wernovsky G. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg 1997;114:376-391.
2. Cetta F, Feldt RH, O'Leary PW, Mair DD, Warnes CA, Driscoll DJ, Hagler DJ, Porter CJ, Offord KP, Schaff HV, Puga FJ, Danielson GK. Improved early morbidity and mortality after Fontan operation: the Mayo Clinic experience, 1987 to 1992. J Am Coll Cardiol 1996;28:480-486.
3. Driscoll DJ, Offord KP, Feldt RH, Schaff HV, Puga FJ, Danielson GK. Five- to fifteen-year follow-up after Fontan operation. Circulation 1992;85:469-496.
4. Gentles TL, Gauvreau K, Mayer JE Jr, Fishberger SB, Burnett J, Colan SD, Newburger JW, Wernovsky G. Functional outcome after the Fontan operation: factors influencing late morbidity. [Discussion 404-405]. J Thorac Cardiovasc Surg 1997;114:392-403.
5. Rosenthal M, Bush A, Deanfield J, Redington A. Comparison of cardiopulmonary adaptation during exercise in children after the atriopulmonary and total cavopulmonary connection Fontan procedures. Circulation 1995;91:372-378.
6. Gewillig M, Daenen W, Aubert A, Van der Hauwaert L. Abolishment of chronic volume overload. Implications for diastolic function of the systemic ventricle immediately after Fontan repair. Circulation 1992;86(Suppl. 5):II93-II99.
7. Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Sasaki N, Asano H, Kyo S, Yokote Y, Ishizawa A. Ventricular afterload and ventricular work in Fontan circulation: comparison with normal two-ventricle circulation and single-ventricle circulation with blalock-taussig shunts. Circulation 2002;105:2885-2892.
8. Senzaki H, Masutani S, Ishido H, Taketazu M, Kobayashi T, Sasaki N, Asano H, Katogi T, Kyo S, Yokote Y. Cardiac rest and reserve function in patients with Fontan circulation. J Am Coll Cardiol 2006;47:2528-2535.
9. Redington AN. The physiology of the Fontan circulation. Prog Pediatric Cardiol 2006;22:179-186.
10. Khambadkone S, Li J, de Leval MR, Cullen S, Deanfield JE, Redington AN. Basal pulmonary vascular resistance and nitric oxide responsiveness late after Fontan-type operation. Circulation 2003;107:3204-3208.
11. Semigran MJ, Cockrill BA, Kacmarek R, Thompson BT, Zapol WM, Dec GW, Fifer MA. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol 1994;24:982-988.
12. Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 1994;90:2780-2785.
13. Michelakis E, Tymchak W, Lien D, Webster L, Hashimoto K, Archer S. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 2002;105:2398-2403.
14. Lepore JJ, Maroo A, Pereira NL, Ginns LC, Dec GW, Zapol WM, Bloch KD, Semigran MJ. Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension. Am J Cardiol 2002;90:677-680.
15. Lewis GD, Lachmann J, Camuso J, Lepore JJ, Shin J, Martinovic ME, Systrom DM, Bloch KD, Semigran MJ. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 2007;115:59-66.
16. Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353:2148-2157.
17. Altman DG, Bland JM. Treatment allocation by minimization. BMJ 2005;330:843.
18. Lehmann G, Kolling K. Reproducibility of cardiopulmonary exercise parameters in patients with valvular heart disease. Chest 1996;110:685-692.
19. Giardini A, Specchia S, Coutsoumbas G, Donti A, Formigari R, Fattori R, Oppido G, Gargiulo G, Picchio FM. Impact of pulmonary regurgitation and right ventricular dysfunction on oxygen uptake recovery kinetics in repaired tetralogy of Fallot. Eur J Heart Fail 2006;8:736-743.
20. Lang CC, Karlin P, Haythe J, Tsao L, Mancini DM. Ease of noninvasive measurement of cardiac output coupled with peak VO2 determination at rest and during exercise in patients with heart failure. Am J Cardiol 2007;99:404-405.
21. Gabrielsen A, Videbaek R, Schou M, Damgaard M, Kastrup J, Norsk P. Non-invasive measurement of cardiac output in heart failure patients using a new foreign gas rebreathing technique. Clin Sci (Lond) 2002;102:247- 252.
22. Agostoni P, Cattadori G, Apostolo A, Contini M, Palermo P, Marenzi G, Wasserman K. Noninvasive measurement of cardiac output during exercise by inert gas rebreathing technique: a new tool for heart failure evaluation. J Am Coll Cardiol 2005;46:1779-1781.
23. Guazzi M, Tumminello G, Di Marco F, Guazzi MD. Influences of sildenafil on lung function and hemodynamics in patients with chronic heart failure. Clin Pharmacol Ther 2004;76:371-378.
24. Koike A, Wasserman K, Taniguchi K, Hiroe M, Marumo F. Critical capillary oxygen partial pressure and lactate threshold in patients with cardiovascular disease. J Am Coll Cardiol 1994;23:1644-1650.
25. Inai K, Saita Y, Takeda S, Nakazawa M, Kimura H. Skeletal muscle hemodynamics and endothelial function in patients after Fontan operation. Am J Cardiol 2004;93:792-797.
26. Guazzi M, Tumminello G, Di Marco F, Fiorentini C, Guazzi MD. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol 2004;44:2339-2348.
27. Raj JU, Kaapa P, Anderson J. Effect of pulsatile flow on microvascular resistance in adult rabbit lungs. J Appl Physiol 1992;72:73-81.
28. Busse R, Fleming I. Pulsatile stretch and shear stress: physical stimuli determining the production of endothelium-derived relaxing factors. J Vasc Res 1998;35:73-84.
29. Guazzi M, Casali M, Berti F, Rossoni G, Gennaro Colonna V, Guazzi M. Endothelium-mediated modulation of ergoreflex and improvement in exercise ventilation by acute sildenafil in heart failure patients. Clin Pharmacol Ther 2007; Epub ahead of print.